Iv to po clindamycin

Topical applications: PROCEDURE: If a patient meets the approved criteria for transition to oral therapy (Section D), the clinical pharmacist will determine if it is clinically appropriate to perform a sequential IV to PO therapy interchange. Actinomycosis: 600 mg IV q 8h x 2-6 weeks, then clindamycin 300 mg PO q6h x 6-12 months

2024-03-29
    Duloxetine hallucinations side effects
  1. g
  2. Intravenous infusion bags are not licensed in children under 12 years
  3. Diluent
  4. mucocutaneous HSV) Severe (e
  5. 1
  6. 900 mg PO/IV 1
  7. Clindamycin
  8. 600 mg PO q8h x 7-10 days; Alt: 300-600mg IV q6h x 7-10 days First
  9. 86%
  10. Saves medical and nursing time
  11. Clindamycin is active against most strains of S
  12. 2g tds + Doxycycline PO 100mg bd Doxycycline 100mg bd Co-amoxiclav 1
  13. Simple answer is po has higher risk of C
  14. May use IV above or oral selection below based on clinical judgment
  15. 04 mg/mL